non-metastatic soft tissue sarcoma research hub

Sarcomas and DDR-Inhibition; a neoadjuvant phase I combined modality study - SADDRIN-1

This early-stage study is for adults with a type of cancer called soft tissue sarcoma that hasn't spread. It's testing a new approach that combines standard treatments with a new medicine to see if it's safe and helps improve outcomes.